• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲更年期与男性健康学会立场声明:更年期健康综合管理十点指南

EMAS position statement: The ten point guide to the integral management of menopausal health.

作者信息

Neves-E-Castro Manuel, Birkhauser Martin, Samsioe Goran, Lambrinoudaki Irene, Palacios Santiago, Borrego Rafael Sanchez, Llaneza Placido, Ceausu Iuliana, Depypere Herman, Erel C Tamer, Pérez-López Faustino R, Schenck-Gustafsson Karin, van der Schouw Yvonne T, Simoncini Tommaso, Tremollieres Florence, Rees Margaret

机构信息

Clinica da Menopausa, Av. Luis Bivar, 93c-1 Dt, Lisboa 1050-143, Portugal.

Gynaecological Endocrinology and Reproductive Medicine, University of Berne, Gartenstrasse 67, CH-4052 Basel, Switzerland.

出版信息

Maturitas. 2015 May;81(1):88-92. doi: 10.1016/j.maturitas.2015.02.003. Epub 2015 Feb 11.

DOI:10.1016/j.maturitas.2015.02.003
PMID:25757366
Abstract

With increased longevity and more women becoming centenarians, management of the menopause and postreproductive health is of growing importance as it has the potential to help promote health over several decades. Women have individual needs and the approach needs to be personalised. The position statement provides a short integral guide for all those involved in menopausal health. It covers diagnosis, screening for diseases in later life, treatment and follow-up.

摘要

随着寿命的延长以及越来越多的女性成为百岁老人,更年期及绝经后健康管理变得愈发重要,因为它有可能在数十年间促进健康。女性有个体需求,应对方法需要个性化。本立场声明为所有参与更年期健康事务的人员提供了一份简短的综合指南。它涵盖了诊断、晚年疾病筛查、治疗及随访。

相似文献

1
EMAS position statement: The ten point guide to the integral management of menopausal health.欧洲更年期与男性健康学会立场声明:更年期健康综合管理十点指南
Maturitas. 2015 May;81(1):88-92. doi: 10.1016/j.maturitas.2015.02.003. Epub 2015 Feb 11.
2
Maintaining postreproductive health: A care pathway from the European Menopause and Andropause Society (EMAS).维持绝经后期健康:欧洲绝经与雄性激素缺乏协会(EMAS)的一条护理路径。
Maturitas. 2016 Jul;89:63-72. doi: 10.1016/j.maturitas.2016.04.013. Epub 2016 Apr 20.
3
Treatment of the genitourinary syndrome of menopause.更年期泌尿生殖综合征的治疗。
Climacteric. 2015;18 Suppl 1:23-9. doi: 10.3109/13697137.2015.1079100.
4
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.绝经泌尿生殖综合征:来自国际女性性健康研究学会和北美更年期协会的外阴阴道萎缩新术语。
Maturitas. 2014 Nov;79(3):349-54. doi: 10.1016/j.maturitas.2014.07.013. Epub 2014 Aug 19.
5
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.更年期泌尿生殖综合征:来自国际女性性健康研究学会和北美更年期协会的外阴阴道萎缩新术语。
J Sex Med. 2014 Dec;11(12):2865-72. doi: 10.1111/jsm.12686. Epub 2014 Aug 25.
6
Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women's Sexual Health and the North American Menopause Society.绝经泌尿生殖综合征:来自国际妇女性健康研究学会和北美更年期协会的外阴阴道萎缩新术语。
Menopause. 2014 Oct;21(10):1063-8. doi: 10.1097/GME.0000000000000329.
7
Bazedoxifene/conjugated estrogens for menopausal symptom treatment and osteoporosis prevention.比戈洛苯/结合雌激素治疗绝经症状和预防骨质疏松症。
Climacteric. 2012 Oct;15(5):411-8. doi: 10.3109/13697137.2012.696289. Epub 2012 Aug 1.
8
British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer.英国更年期协会关于早期乳腺癌女性患者雌激素缺乏症状、关节痛及更年期诊断管理的共识声明
Post Reprod Health. 2019 Mar;25(1):21-32. doi: 10.1177/2053369118824920. Epub 2019 Feb 18.
9
Characteristics of post-menopausal women with genitourinary syndrome of menopause: Implications for vulvovaginal atrophy diagnosis and treatment selection.绝经后女性泌尿生殖综合征的特征:对外阴阴道萎缩诊断和治疗选择的意义。
Maturitas. 2015 Aug;81(4):462-9. doi: 10.1016/j.maturitas.2015.05.007. Epub 2015 May 30.
10
Treating vulvovaginal atrophy/genitourinary syndrome of menopause: how important is vaginal lubricant and moisturizer composition?治疗外阴阴道萎缩/绝经后泌尿生殖综合征:阴道润滑剂和保湿剂的成分有多重要?
Climacteric. 2016 Apr;19(2):151-61. doi: 10.3109/13697137.2015.1124259. Epub 2015 Dec 26.

引用本文的文献

1
Qualitative exploration of women's experiences of vasomotor symptoms to support the content validity of patient-reported outcomes.对女性血管舒缩症状体验的质性探索,以支持患者报告结局的内容效度。
J Patient Rep Outcomes. 2025 Jul 1;9(1):79. doi: 10.1186/s41687-025-00914-0.
2
Psychometric evaluation of the HFDD, PROMIS SD SF 8b, and MENQOL questionnaire in women experiencing vasomotor symptoms associated with menopause.对经历绝经相关血管舒缩症状的女性进行高频数字判别测验(HFDD)、患者报告结果测量信息系统简版身体功能8b量表(PROMIS SD SF 8b)和更年期症状问卷(MENQOL)的心理测量学评估。
J Patient Rep Outcomes. 2025 May 7;9(1):50. doi: 10.1186/s41687-025-00875-4.
3
Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies.
非索利那新治疗绝经引起的中度至重度血管舒缩症状的安全性:三项随机3期研究的汇总分析
Adv Ther. 2025 Feb;42(2):1147-1164. doi: 10.1007/s12325-024-03073-8. Epub 2024 Dec 30.
4
Considerations in Premature Menopause: A Review.早发性绝经的相关考量:综述
Cureus. 2024 Sep 19;16(9):e69744. doi: 10.7759/cureus.69744. eCollection 2024 Sep.
5
Efficacy and safety of fezolinetant for moderate to severe vasomotor symptoms associated with menopause among women in East Asia: a phase 3 randomized study (MOONLIGHT I).在东亚女性中,fezolinetant 治疗与绝经相关的中度至重度血管舒缩症状的疗效和安全性:一项 3 期随机研究(MOONLIGHT I)。
J Int Med Res. 2024 May;52(5):3000605241247684. doi: 10.1177/03000605241247684.
6
Validation and Application of Thresholds to Define Meaningful Change in Vasomotor Symptoms Frequency: Analysis of Pooled SKYLIGHT 1 and 2 Data.验证和应用阈值来定义血管舒缩症状频率的有意义变化:SKYLIGHT 1 和 2 数据的汇总分析。
Adv Ther. 2024 Jul;41(7):2845-2858. doi: 10.1007/s12325-024-02849-2. Epub 2024 May 22.
7
Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause.系统评价和网络荟萃分析比较非激素疗法 fezolinetant 与激素和非激素疗法治疗绝经相关血管舒缩症状的疗效。
Menopause. 2024 Jan 1;31(1):68-76. doi: 10.1097/GME.0000000000002281. Epub 2023 Nov 27.
8
Association of menopausal vasomotor symptom severity with sleep and work impairments: a US survey.绝经血管舒缩症状严重程度与睡眠和工作障碍的关系:一项美国调查。
Menopause. 2023 Sep 1;30(9):887-897. doi: 10.1097/GME.0000000000002237.
9
Surgical Menopause and Estrogen Therapy Modulate the Gut Microbiota, Obesity Markers, and Spatial Memory in Rats.手术绝经和雌激素治疗可调节大鼠肠道微生物群、肥胖标志物和空间记忆。
Front Cell Infect Microbiol. 2021 Sep 30;11:702628. doi: 10.3389/fcimb.2021.702628. eCollection 2021.
10
Progestins and the Risk of Breast Cancer.孕激素与乳腺癌风险
Acta Endocrinol (Buchar). 2021 Apr-Jun;17(1):90-100. doi: 10.4183/aeb.2021.90.